Specialities and Expertise:Research & Development, Novel Therapeutic Antibodies, Monoclonal Antibodies, Immunogenicity, Synthetic Universal Flu Vaccine, Vaccine Development, Cross-Protective Monoclonal Antibodies, H5N1 Protective Vaccine, Viral Infection, Immunocastration, Multivalent Peptide Vaccine, Conjugate Vaccines, Influenza Vaccines.
Size and Minority Status
- Products and services 2
- Сommodity codes
TRIA Bioscience is focusing on the development of conjugate vaccines. Conjugate vaccines replace traditional protein carriers with smaller synthetic peptides and are very effective in preventing pneumonia and meningitis.
TRIA Biosciences is developing a multi-valent universal Flu vaccine using a proprietary synthetic peptide to achieve robust immune responses to traditionally weak antigens.
Locations Served 1
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.